Find policies, billing codes, payers, states, and providers
Pneumatic Compression Devices (for Nebraska Only)
Customize your policy alerts
Sign up for UnitedHealthcare Policy CS097NE.T alerts
Get alerted when Policy CS097NE.T changes without checking for updates manually.
Monitor payer policy activity
State-specific UnitedHealthcare Community Plan medical policy governing coverage and medical necessity criteria for pneumatic compression devices for members in Nebraska.
Replaced instruction to refer to Nebraska DHHS Code for coverage information with reference to the same Code for medical necessity clinical coverage criteria.
Replaced reference to 'InterQual ® CP: Durable Medical Equipment, Pneumatic and other Powered Compression Devices' with 'InterQual ® CP: Durable Medical Equipment, Pneumatic Compression Devices'.
Added language that intermittent limb compression devices are proven and medically necessary for DVT prevention when InterQual subset criteria are met.
Added detailed Medical Records Documentation Used for Reviews section describing required documentation elements and that documentation may be required to assess clinical criteria.
Updated Clinical Evidence and References sections to reflect current information.
Coverage and Clinical Criteria
Primary coverage logic
Coverage stance references state statute and InterQual clinical criteria; coverage and medical necessity decisions depend on meeting those criteria.
See InterQual CP: Durable Medical Equipment, Pneumatic Compression Devices for item-level clinical entry criteria
InterQual CP: Durable Medical Equipment, Pneumatic Compression Devices; providers must consult the referenced InterQual subset for specific entry and continuation criteria
Covered with conditions by indication
Guideline-supported, condition-dependent coverage statements (summarized):
Document rationale and prior/attempted therapies; consider prior authorization
Document prior use of stockings, multilayer bandages, or adjustable compression garments and reasons they are not appropriate or have failed
Indication, duration, and contraindications should be documented per trials and guideline recommendations
Medical necessity (referenced criteria)
Coverage is determined when medical necessity clinical criteria in the referenced InterQual subset and Nebraska DHHS Code § 471-7-004.02(VV) are met.
When InterQual subset criteria are met, intermittent limb compression devices are considered proven and medically necessary for prevention of deep venous thrombosis; consult InterQual and state code for item-level requirements
Advanced pneumatic compression devices (APCDs) intended to treat lymphedema of the head, face, or neck are classified in this policy as unproven and not medically necessary. The policy cites insufficient peer-reviewed evidence to establish efficacy, clinical value, or safety for APCDs in head/neck lymphedema and requires additional research to define their role.
The policy also flags device design features and indications as relevant coverage nuances: high-pressure, rapid inflation/deflation pneumatic compression devices used for peripheral arterial disease (PAD) or arterial insufficiency are likewise considered unproven and not medically necessary in this excerpt.
For peripheral arterial disease (PAD) the policy highlights uncertain benefit: systematic reviews and technology assessments report inconsistent evidence and study limitations. Notably, published evidence showed no proven benefit for decreasing edema compared with compression stockings after peripheral bypass surgery, and existing PAD studies suffer from small sample sizes, risk of bias, and heterogeneity, limiting definitive conclusions about IPC effectiveness.
Guidance is therefore that IPC for PAD remains of uncertain clinical value and should not be substituted for standard compression modalities where those are effective and appropriate.
Clinical practice guidance included in the policy (NICE) recommends that mechanical prophylaxis, including IPC, should not be used in patients with suspected or proven peripheral arterial disease, peripheral arterial bypass grafting, peripheral neuropathy or other sensory impairment, local conditions that may be harmed by mechanical pressure (e.g., fragile skin, dermatitis, gangrene, recent skin graft), severe leg edema, or major limb deformity or unusual leg size that prevents correct fit.
These contraindications are presented as coverage cautions: use in these settings may be denied or considered inappropriate because mechanical compression could cause harm or be ineffective.
The policy excerpt does not enumerate a separate list of device exclusions beyond the APCD and high‑pressure PAD statements. Coverage determinations are governed by federal, state, or contractual requirements, and the policy explicitly references Nebraska DHHS Code § 471-7-004.02(VV) plus the InterQual subset for medical necessity criteria; providers should follow those sources and applicable plan terms when evaluating device eligibility.
Summarizing the policy's Not Medically Necessary stance: APCDs for head/neck lymphedema and high‑pressure pneumatic compression devices used for arterial insufficiency/PAD are characterized as unproven and not medically necessary in this document due to insufficient evidence of efficacy and safety.
When assessing requests involving these devices, the policy directs reviewers to the cited evidence gaps and to the InterQual criteria and state code for any scenarios where a different determination might be warranted.
The clinical evidence summarized in the policy shows a nuanced picture for DVT prevention: pooled analyses and systematic reviews indicate IPC reduces DVT incidence compared with no prophylaxis in some surgical populations, but comparisons versus pharmacologic prophylaxis show no consistent superiority. For example, a 2024 meta-analysis of surgical RCTs found IPC did not differ significantly from pharmacotherapy for DVT prevention, while large trials in critically ill patients (Arabi et al.) found that adding IPC to pharmacologic prophylaxis did not reduce proximal DVT incidence.
The policy therefore recognizes that IPC can be beneficial compared with no prophylaxis in selected settings but that its incremental benefit versus pharmacologic agents is variable and evidence‑dependent; InterQual and clinical guidelines should be consulted for indication‑specific recommendations.
The excerpt does not provide a separate enumerated list of explicit Not Medically Necessary (NMN) denial reasons beyond the APCD/head‑neck and high‑pressure PAD statements. Denials may occur when the submitted documentation fails to demonstrate that the member meets the referenced InterQual/state medical necessity criteria or when required medical records (history, exam, diagnostic test results) are incomplete or unavailable.
The policy notes that documentation may be requested to assess criteria and that providing records does not guarantee coverage — reviewers will apply the InterQual subset and Nebraska DHHS Code § 471-7-004.02(VV) to determine medical necessity.
Applicable Codes
| A4600 | Sleeve for intermittent limb compression device, replacement only, each. |
| E0650 | Pneumatic compressor, nonsegmental home model. |
| E0651 | Pneumatic compressor, segmental home model without calibrated gradient pressure. |
| E0652 | Pneumatic compressor, segmental home model with calibrated gradient pressure. |
| E0655 | Nonsegmental pneumatic appliance for use with pneumatic compressor, half arm. |
| E0658 | Segmental pneumatic appliance for use with pneumatic compressor, integrated, 2 full arms and chest. |
| E0659 | Segmental pneumatic appliance for use with pneumatic compressor, integrated, head, neck and chest. |
| E0660 | Nonsegmental pneumatic appliance for use with pneumatic compressor, full leg. |
| E0665 | Nonsegmental pneumatic appliance for use with pneumatic compressor, full arm. |
| E0666 | Nonsegmental pneumatic appliance for use with pneumatic compressor, half leg. |
Prior Authorization, Sequencing, and Regulatory Notes
Prior authorization and InterQual/state medical necessity
Medical necessity determinations for pneumatic compression devices are governed by Nebraska DHHS Code § 471-7-004.02(VV) and the InterQual® CP: Durable Medical Equipment, Pneumatic Compression Devices subset; prior authorization requests must reference and demonstrate that the member meets those InterQual/state medical necessity criteria.
- When InterQual criteria are met, intermittent limb compression devices are considered proven and medically necessary for prevention of deep venous thrombosis.
Prior authorization recommended for IPC in CLI/VLU
When considering IPC for chronic limb‑threatening ischemia (CLI) or venous leg ulcers (VLU), obtain prior authorization that documents the clinical rationale, prior or concurrent therapies, and why revascularization or standard compression is not possible or has failed.
- ESVS and AHA/ACC guidelines support IPC in selected CLI patients when revascularization is not an option (grade 2B).
- For active VLU, IPC should be considered only when other compression options are unavailable, cannot be used, or have failed (ESVS grade 2a).
Regulatory status (informational)
Devices and systems to perform pneumatic compression are FDA‑regulated Class II devices (product code JOW); FDA clearance information is provided for informational purposes only and does not guarantee coverage.
- Flexitouch Plus received FDA clearance (Dec 20, 2020) — informational only.
- Device product code: JOW (Class II).
Prior authorization — reference InterQual and state code
Coverage decisions and any required prior authorization must reference InterQual® CP: Durable Medical Equipment, Pneumatic Compression Devices and Nebraska DHHS Code § 471-7-004.02(VV) as the sources of the medical necessity clinical criteria.
- Policy revision explicitly operationalizes Nebraska DHHS Code and the InterQual subset as governing medical necessity criteria.
Provider alert: key policy highlights
Providers should note the following highlighted policy points when preparing authorization requests: IPC is considered medically necessary for DVT prevention when InterQual criteria are met, and advanced APCDs for head/neck lymphedema and high‑pressure devices for PAD are considered unproven and not medically necessary.
- Intermittent limb compression devices are proven and medically necessary for DVT prevention when InterQual criteria are met.
- APCDs for head/neck lymphedema and high‑pressure PAD devices are considered unproven/not medically necessary.
Step‑therapy: document trial/failure of standard compression first
Document prior use and failure (or inability to use) of standard compression therapies before requesting IPC for VLU/CVD—standard compression (stockings, multilayer bandages, adjustable compression garments) is preferred first‑line.
- ESVS recommends multilayer bandages, IBs, or ACG with target ankle pressure ≥40 mm Hg as first‑line for VLU (grade 1A).
- IPC is suggested only when other compression options are unavailable, cannot be used, or have failed (ESVS grade 2a).
Guideline‑based sequencing: favor pharmacologic prophylaxis when appropriate
For VTE prophylaxis sequencing, assess both VTE and bleeding risk and prioritize pharmacologic prophylaxis when not contraindicated; use IPC when pharmacologic methods are contraindicated or as adjunctive therapy in high‑risk patients per guideline recommendations.
- ASH and European guidelines recommend assessing bleeding risk and favor pharmacologic prophylaxis when possible; mechanical prophylaxis is preferred when bleeding risk is high.
- Combined pharmacologic plus mechanical prophylaxis may be suggested in patients at very high VTE risk.
Provide concise clinical rationale and make records available on request
Additional provider guidance: document and justify use of IPC in the clinical context (indication, setting, and expected benefit), and be prepared to supply supporting medical records upon request for coverage review.
- Policy change notes emphasize that documentation may be requested and that coverage is governed by federal/state/contractual rules.
- Include clinical rationale and prior/concurrent therapies in the authorization submission.
Medical record documentation required for reviews
The patient’s medical record must fully support the request: include relevant medical history, focused physical examination findings, and results of pertinent diagnostic tests or procedures; records must be legible and available on request.
- Medical records documentation may be required to assess whether the member meets clinical criteria but does not guarantee coverage.
- Documentation should include history, exam, and diagnostic test results and be maintained in the patient’s medical record.
Document device application duration and frequency
When reporting device use, include the application duration and frequency (hours per day and number of days); clinical trials cited specific daily and total durations that are relevant to justification.
- Arabi et al. reported IPC applied a median of 22 hours daily for a median of 7 days in ICU patients.
- Trials and cohort reports specify mean/median daily hours and total days—document actual planned/observed use in the record.
Document clinical condition and any contraindications
When justifying IPC, document the patient’s clinical status and any contraindications per trial inclusion/exclusion examples (for example, immobility definition) to demonstrate applicability of evidence to the patient.
- CLOTS 3 trial defined immobility as unable to get up and walk to the toilet without help; exclusions included dermatitis, leg ulcers, severe edema, severe peripheral vascular disease, and congestive cardiac failure.
- Use trial criteria to support that the patient matches populations where benefit was demonstrated.
Make complete medical records available when requested
Medical records used for authorization and coverage review must be made available upon request; failure to provide complete, legible documentation that supports medical necessity may result in denial.
- Policy explicitly states that documentation may be required to assess whether the member meets clinical criteria and that documentation does not guarantee coverage.
- Lack of sufficient records may lead to inability to determine coverage or denial.
Denial risk: APCDs for head/neck lymphedema
Advanced pneumatic compression for head/neck lymphedema is considered unproven and not medically necessary; submitting authorization for these indications carries a high risk of denial.
- Policy states APCDs (e.g., Flexitouch) for head/face/neck lymphedema are unproven and not medically necessary.
- Applicable HCPCS include E0659 for head, neck and chest garments and codes for APCD systems—coverage denied for head/neck lymphedema per policy.
Denial risk: low‑quality or insufficient evidence for PAD/CLI indications
Insufficient, low‑quality, or conflicting evidence for PAD or certain CLI indications may lead to noncoverage; provide robust supporting data if requesting IPC for PAD/CLI outside guideline‑recommended, selected scenarios.
- Hayes HTA found low‑quality, small RCTs for IPC in PAD with uncertainty about safety and health outcomes.
- Guidelines allow IPC only in carefully selected CLI patients when revascularization is not possible (grade 2B)—document why patient fits that subset.
Contraindications: conditions that may lead to denial
Do not request mechanical prophylaxis for patients with suspected or proven peripheral arterial disease, recent peripheral arterial bypass grafting, sensory impairment, fragile or damaged skin, severe leg edema, or severe limb deformity—these contraindications are grounds for denial.
- NICE lists suspected/proven PAD, peripheral arterial bypass grafting, sensory impairment, local conditions that may be damaged by mechanical prophylaxis (fragile skin, dermatitis, gangrene, recent graft), severe leg edema, and major limb deformity as contraindications.
- European perioperative guidance similarly highlights assessment of fit and contraindications before using mechanical prophylaxis.
Denial risk: documentation insufficiency
If documentation is incomplete, illegible, or does not demonstrate that InterQual/state medical necessity criteria are met, the request may be denied or remain indeterminate; include all requested records and specific chart excerpts that address criteria.
- Policy states that lack of sufficient medical records may result in denial or inability to determine coverage.
- Ensure history, exam, diagnostic test results, prior treatments, and rationale are clearly presented in the record.
Medical Necessity Determinations and Scenarios
DME medical necessity governance
Medical necessity is determined by Nebraska DHHS Code § 471-7-004.02(VV) and InterQual clinical criteria; when InterQual criteria are met devices are considered medically necessary for specified indications.
Policy operationalizes the state code as the source of medical necessity clinical criteria and directs providers to InterQual for clinical detail
DME medical necessity scenarios
Clinical scenarios where IPC may be medically necessary or reasonable:
Document vascular assessment, reasons revascularization is not feasible, and anticipated goals of therapy
Document prior compression modalities, duration of therapy, and wound response
Document VTE and bleeding risk assessment, contraindications to IPC, and planned duration of use
Evidence-supported clinical scenarios (examples)
Clinical evidence supports IPC use in select populations when documented reasons exist (examples from trials and meta-analyses):
Trials differ in populations and duration of application; document similarity to trial inclusion criteria (e.g., immobility) when justifying use
DME medical necessity (referenced)
Medical necessity is determined by the InterQual CP subset and Nebraska DHHS Code § 471-7-004.02(VV).
Specific clinical entry and continuation criteria are contained in the referenced InterQual subset and state code; providers must consult those sources and maintain complete documentation for review
Device Use, Rental vs Purchase, and System Types
| Item | Policy detail / supporting text |
|---|---|
| Intermittent pneumatic compression (IPC) devices (clinical trial use) | Clinical trials report daily application durations and short-term inpatient use (example: Arabi et al. — IPC applied a median of 22 hours daily for a median of 7 days in a multisite ICU RCT). |
| Payer rental vs. purchase rule in excerpt | No explicit payer rental‑versus‑purchase rule text is provided in the document excerpt; the excerpt documents clinical use patterns (hours/day, duration) but does not specify billing rental or purchase rules. |
| System / equipment | Billing guidance summary |
|---|---|
| IPC systems and advanced devices (examples: Flexitouch Plus and other FDA‑regulated systems) | Devices and systems to perform pneumatic compression are FDA‑regulated Class II devices; the policy notes device regulatory status for informational purposes but does not mandate a purchase versus rental approach. (See FDA clearance information for specific products such as Flexitouch Plus.) |
| Payment model indicated in excerpt | The excerpt provides no explicit rental or purchase rule; it references device regulation and product clearances but leaves billing model (rental vs purchase) to plan/state DMEPOS rules. |
| Operational note | Action / direction |
|---|---|
| Rental/purchase policy presence in excerpt | No rental or purchase rules are specified in this policy excerpt. Providers should refer to the member's plan benefit terms and applicable state DMEPOS rules for billing/rental versus purchase determinations. |
| Medical necessity and coverage governance | Coverage and medical necessity determinations reference Nebraska DHHS Code § 471-7-004.02(VV) and the InterQual® CP: Durable Medical Equipment, Pneumatic Compression Devices subset; adherence to those criteria does not, by itself, specify rental versus purchase billing. Refer to plan/state rules for operational billing decisions. |
Replacement and Repair Guidance
Medical Records and Documentation Requirements
Medical records documentation — include history, exam, and diagnostic results
Medical records documentation supporting medical necessity must include relevant medical history, a focused physical examination, and results of pertinent diagnostic tests or procedures; documentation must be legible and available upon request.
- Include problem‑specific history, objective findings, and any imaging or vascular studies used to justify device use.
Device use recording — document application duration and frequency
Record and document device application duration and frequency when clinically relevant; trials report specific daily hours and treatment durations that may inform justification.
- Example: IPC applied a median 22 hours/day for a median of 7 days in a multisite ICU trial; CLOTS 3 reported mean IPC use ≈11 days.
Immobility & contraindication documentation — document status and absence of contraindications
Document immobility status and the absence of contraindications to IPC (for example, dermatitis, leg ulcers, severe edema, severe peripheral vascular disease, congestive heart failure) when justifying device use.
- Use trial definitions where applicable (CLOTS 3 definition of immobile: unable to get up and walk to the toilet without help).
Provide complete medical records when requested for review
Provide complete, legible medical record documentation when requested for review to support medical necessity determinations; include history, exam, diagnostic tests, prior therapies, and device‑use details.
- Make records available promptly on request to avoid delays or denials.
Items and Uses Considered Not Medically Necessary
APCDs intended for treatment of head, face, or neck lymphedema and high‑pressure pneumatic compression devices for PAD/arterial insufficiency are listed in the policy as not covered / not medically necessary in this excerpt due to insufficient evidence to support efficacy or safety.
These not‑covered determinations are based on published evidence limitations and technology assessments cited in the policy and should be applied in claims and prior authorization reviews consistent with InterQual and state rules.
The policy cautions against using IPC as a routine replacement for standard compression when standard options (e.g., compression stockings or multilayer bandaging) are available and effective for treating venous leg ulcers. Comparative evidence reviewed in technology assessments found no proven superiority of IPC over conventional compression in some PAD/postoperative contexts, supporting the position that IPC should not supplant standard compression when those therapies are appropriate.
As a result, requests that seek IPC solely as a substitute for effective standard compression for VLU are unlikely to meet medical necessity unless documented clinical reasons show standard options are unavailable, cannot be used, or have failed.
Reiterating the inventory guidance: comparative assessments and clinical guidance indicate IPC should not be used as a direct replacement for standard compression therapies when those therapies are effective. The policy references evidence and assessments that found no additional benefit of IPC compared with established compression modalities in some settings.
Coverage evaluators should require documentation that standard compression was tried and failed or is contraindicated before approving IPC as an alternative for VLU or related indications.
Duplicate inventory rationale: where standard compression options are available and effective, the policy treats IPC replacement requests with caution. Evidence syntheses and clinical assessments cited in the policy do not support routine substitution of IPC for conventional compression in venous disease or postoperative edema management.
Clinical justification that standard compression cannot be used or has failed should be documented to support IPC use in these circumstances.
The excerpt does not list particular DME items beyond the APCD/head/neck and high‑pressure PAD statements as universally not covered. The policy instructs reviewers to follow the InterQual CP subset and applicable federal, state, or contractual requirements (e.g., Nebraska DHHS Code § 471-7-004.02(VV)) for item‑level coverage decisions.
Practices for rental vs purchase, replacement intervals, and other DME specifics are not specified in this excerpt and should defer to plan, state, and DMEPOS rules.
Background and Evidence Overview
Background: Pneumatic compression devices consist of a compressor unit and inflatable garments or sleeves that sequentially inflate and deflate to reduce edema, augment venous return, and in some contexts provide mechanical prophylaxis against venous thromboembolism. Devices range from simple intermittent pneumatic compression (IPC) sleeves used on the calf or thigh to more complex, programmable advanced pneumatic compression devices (APCDs) with multiple garment configurations for localized or difficult‑to‑treat lymphedema.
The policy frames these device types within clinical indications and evidence reviews, noting that device classification and intended use (e.g., DVT prophylaxis, lymphedema management, PAD therapy) affect the coverage stance.
Key Terms and Device Definitions
Clinical Evidence and References
The policy's Clinical Evidence and References sections were updated to reflect multiple recent systematic reviews, meta‑analyses, technology assessments, and randomized trials cited in the document (for example, Kim et al. 2024, Arabi et al. 2019, Cochrane reviews and guideline sources).
References include national guidance (NICE), specialty and systematic review literature, and specific trials and technology assessments that underpin the policy statements; providers should consult the cited references for detailed study findings and applicability.
Policy Changes
Replaced instruction to refer to Nebraska DHHS Code for coverage information with a reference to the same Code for medical necessity clinical coverage criteria.
Replaced reference to 'InterQual ® CP: Durable Medical Equipment, Pneumatic and other Powered Compression Devices' with 'InterQual ® CP: Durable Medical Equipment, Pneumatic Compression Devices'.
Added language stating intermittent limb compression devices are proven and medically necessary for prevention of deep venous thrombosis when InterQual subset medical necessity criteria are met.
Added detailed 'Medical Records Documentation Used for Reviews' language specifying that documentation may be required to assess clinical criteria, listing required elements (relevant history, physical exam, diagnostic test results), and noting documentation does not guarantee coverage.
Updated Clinical Evidence and References sections to reflect current information.
OpenPayer is powered by Trek Health's payer performance platform. Trek continuously ingests, validates, and normalizes Transparency in Coverage data alongside payer policies and other commercial payer data to create a structured payer intelligence foundation. OpenPayer uses this foundation to deliver personalized search results, dynamically generated policy pages, and tailored policy monitoring based on each user's payers, specialties, billing codes, and areas of interest. The same intelligence powers broader payer performance workflows, including reimbursement benchmarking, contract evaluation, payer negotiations, and financial decision-making.